Long-lasting complete response to SHR-1701 plus famitinib in refractory advanced gallbladder cancer: A case report

ABSTRACTBiliary tract cancer (BTC) is an aggressive malignancy with few options for advanced-stage treatment. The combination of PD-1/PD-L1 inhibitors with famitinib, a receptor tyrosine kinase (RTK) inhibitor, has demonstrated improved clinical outcomes in several clinical trials. We herein reporte...

Full description

Saved in:
Bibliographic Details
Main Authors: Lixia Yi (Author), Xiaoyan Zhu (Author), Jing Xie (Author), Zhiqiang Meng (Author)
Format: Book
Published: Taylor & Francis Group, 2023-12-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available